Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20210612051545N3Phase 2Completed
Phase 2, randomised trial comparing Microneedling + human placenta extract hydrogel with Microneedling + placebo saline (2 arms). Primary endpoint: Safety and tolerability of human placenta extract treatment. Started Sep 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20210612051545N3.